Atlas Trials

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Clinical trial NCT04991948 · RECRUITING

Trial details

NCT number
NCT04991948
Sponsor
Celyad Oncology SA
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Unresectable Metastatic Colorectal Cancer
Start date
2021-11-22
Primary completion
2023-08-21
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.